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Wednesday, February 24, 2010 651aa cytoprotective effect. Intermolecular FRET was used to characterize the to-
pology, packing and dimensions of IAPP oligomers. FRET measurements pro-
vided experimental constraints for atomistic modeling and MD simulations
both of IAPP monomers and oligomers. Simultaneously, we have used fluores-
cence correlation spectroscopy (FCS) to explore the interactions of IAPP with
lipid bilayers, probing the thermodynamic landscape of membrane-catalyzed
IAPP oligomer assembly. Single-molecule techniques provide unique experi-
mental insight into the processes governing the membrane binding and aggre-
gation of IAPP and similar amyloidogenic peptides.
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Aggregation of misfolded proteins is a hallmark of several neurodegenerative
diseases such as Huntington’s disease (HD). HD is caused by a mutation of
Huntingtin caused by an elongation of a polyglutamine (polyQ) sequence in
the protein. Here we describe the application of the recently developed Number
and molecular Brightness method (N&B) to monitor the aggregation process of
Huntingtin exon1 (Httex1). N&Bmeasures the molecular brightness of the pro-
tein aggregates in the entire cell non-invasively based on the fluctuation dy-
namics at each pixel of an image. This analysis provides a map of aggregation
with pixel resolution.
We observed the behavior of Httex1-97QP-EGFP this is a construct with 97
polyQ repeats corresponding to Juvenile onset of the disease.
We preformed experiments in ST14A cells transfected with Httex1-97QP-
EGFP. We establish that the process of nucleation leading to inclusion forma-
tion has four phases: i) Initially only monomers are present; ii) Following an
increase in protein concentration (~1 mM), due to protein accumulation, small
oligomers (8-15 proteins) form throughout the cell; iii) At higher protein con-
centrations, an inclusion is formed in the cytoplasm; iv) The inclusion recruits
most of the Httex1 protein in the cell, including those in the nucleus, leaving
only monomers at very low concentration.
We also performed cross-N&B analysis to measure the size of the oligomeric
species. Cross-N&B recovers the stoichiometry of the complexes from the
simultaneous fluctuations of the fluorescence intensity in two image channels.
The experiments were done on ST14A cells co-transfected with Httex1-97QP-
EGFP and Httex1-97QP-mCherry. These experiments confirmed the mecha-
nism of aggregation observed by N&B and the range of size of the oligomers.
Work supported by NIH-P41-RRO3155, P50-GM076516, NIH NS045283
(J. L. M.),Optical Biology Shared Resource of the Cancer Center Support Grant
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Amyloid protein aggregates are believed to be the key cause of neurodegenera-
tive diseases such as Alzheimer’s and Parkinson’s, but the mechanism of their
biological action is far from understood. Different studies have implicated dif-
ferent aggregated forms of these proteins as the key toxic elements. Signifi-
cantly, these studies typically use concentrations in the mM range to get the pro-
teins to aggregate, but this is at least an order of magnitude higher than the
concentrations observed in vivo. Here we examine the aggregation of amyloid
beta (Ab) and a-synuclein on cell membranes and inside live cells at sub-mM
concentrations, using coupled fluorescence correlation spectroscopy, confocal
microscopy and time correlated single photon counting techniques. For Ab,
we find that only small aggregates (<6 nm hydrodynamic radius) form at
350 nM concentration in vitro, but large aggregates of Ab are present on the
cell membrane, together with much smaller species (monomers or small oligo-
mers). When the in vitro concentration is lowered to 150 nM, the solution struc-
tures are even smaller (<4 nm, but significantly, still at least dimeric) and no
largemultimers form on the membrane, though the smaller species are still pres-
ent. We conclude that Ab aggregates at much lower concentrations on the mem-
brane, possibly because of the lower free energy of association required for such
aggregation in a two dimensional system. For a -synuclein, we find that
a 550 nM solution which does not form any aggregates in the extra- cellular me-
dium, develops large aggregates in the cytoplasm. Our results challenge the hy-
potheses that specific aggregate structures (e.g. donut shaped, spherical or proto-
fibrillar aggregates) that form in the solution phase are responsible for the phys-
iological effects of Ab or a -synuclein.3389-Pos
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Amyloid beta (Ab) is 4 kDa peptide which forms aggregates such as oligomers
and fibrils. They have been considered to cause Alzheimer’s diseases (AD). Re-
cent results have suggested that soluble Ab oligomers are the causative agent of
AD since such oligomers are more cytotoxic than fibrils. It was also suggested
that Ab oligomers affect not only cell death but also early stage of cell dysfunc-
tion and cause memory loss.
However, the formation mechanism of these soluble oligomers is still un-
known. In this study, we developed new single molecule analysis method
that can analyze Ab oligomer distribution. For this purpose, we combined total
internal reflection fluorescence microscopy (TIRFM) with photon counting his-
togram (PCH) (Terada, N. et al. (2007) Biophys. J. 92, 2162). Using TIRFM,
fluorescent intensity of monomer is obtained from discrete photobleaching. Us-
ing PCH method, the number of protomers in oligomers and concentrations are
obtained from histograms of photons from fluorescent molecules diffusing
through the confocal volume.
A model Ab oligomer was prepared by sonication treatment of Ab fibrils made
from FITC labeled Ab monomer. The number of Ab monomer in a single Ab
oligomer was estimated by TIRFM, which agrees well with the results of PCH
analysis. Thus we concluded that PCH can be applied to analyze Ab oligomer
formation. Next, Ab oligomers were formed at physiological Ab concentration
(LeVineIII, H. (2004) Anal. Biochem. 335, 81). Oligomer formation was ob-
served with TIRFM analysis. PCH analysis is now in pregress.
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The nucleation and growth mechanisms in amyloid forming materials are of
high interest due to their importance in human diseases and also due to their
potential applications as functional nano-materials. While much is known
about the b-sheet secondary structure of amyloids, the nucleation mechanism
and self-assembly processes remain poorly understood. Multiple intermediate
species have been proposed to play important roles in the self assembly
process, yet these states remain poorly defined or have not been unambiguously
identified in solution. We have used single molecule fluorescence spectros-
copy and two-photon fluorescence imaging to investigate early events in
amyloid nucleation and growth. Our observations have demonstrated that
unstructured protein aggregates play a key role in the earliest phases of self
assembly.
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The devastating symptoms of Alzheimer’s Disease (AD) have been attributed
to the behavior of aggregated Amyloid-b (Ab) peptides. Cleaved from the ex-
tra-cellular portion of the transmembrane receptor, amyloid precursor protein
(APP), Ab has a very high propensity to aggregate into fibrils with a cross-b-
sheet structure. Though fibrillar plaques have been seen as a hallmark of AD,
there has recently been increasing evidence suggesting that smaller soluble
Ab oligomers are the agents of neuronal toxicity. Molecular level characteriza-
tion of these oligomers using conventional biochemical techniques has been
very difficult as they are both short-lived and heterogeneous.
In this work we have used a single molecule fluorescence microscopy technique
to follow the formation and resolve distributions of these oligomers. Two-color
coincidence detection (TCCD) has the ability to detect such transient com-
plexes even when they comprise only 0.1% of the population (1, 2). In this
work, we have detected and characterized the species ranging from dimers to
50-mers formed during the oligomerization of monomeric Ab1-40 (the 40-
amino acid portion of Ab) as well as those resulting from breakage of Ab1-40
fibrils. Through experiments tracking the formation of oligomers throughout
the Ab aggregation process in real-time, we have gained novel insights into
the mechanisms of oligomer formation and fibril breakage.
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